NAT-CETIRIZINE

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: f939f9337b10b659
Drug Approval Canada Name: NAT-CETIRIZINE
Product Name: NAT-CETIRIZINE
Status: Marketed
Status Date: 2020-08-19
Original Market Date: 2020-08-19
Din: 02496488
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 04:08.00
Atc Original: R06AE07 CETIRIZINE
Atc Name: r 06 ae 07
Aig Number: 0122686003
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

CETIRIZINE HYDROCHLORIDE

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f939f9337b10b659

Type

Standard